These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10931746)

  • 1. Growth hormone treatment increases transmural colonic growth in GH-deficient dwarf rats.
    Tei TM; Kissmeyer-Nielsen P; Christensen H; Flyvbjerg A
    Growth Horm IGF Res; 2000 Apr; 10(2):85-92. PubMed ID: 10931746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of growth hormone on bone: bone mineral density, trabecular bone volume, and alkaline phosphatase improve or are restored in the dwarf rat treated with growth hormone.
    Wright NM; Renault J; Hollis B; Bell NH; Key LL
    J Bone Miner Res; 1995 Jan; 10(1):127-31. PubMed ID: 7747619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the somatogenic action of 20 kDa- and 22 kDa-human growth hormones in spontaneous dwarf rats.
    Ishikawa M; Tachibana T; Kamioka T; Horikawa R; Katsumata N; Tanaka T
    Growth Horm IGF Res; 2000 Aug; 10(4):199-206. PubMed ID: 11032703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of polyethylene glycol recombinant human growth hormone on growth and glucose metabolism in hypophysectomized rats.
    Zhang ZX; Liu YK; Pan H; Pan L; Zhang Q; Su HM; Zhao QL; Li H; He C
    Growth Horm IGF Res; 2012 Feb; 22(1):30-5. PubMed ID: 22257554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults.
    Giannoulis MG; Boroujerdi MA; Powrie J; Dall R; Napoli R; Ehrnborg C; Pentecost C; Cittadini A; Jørgensen JO; Sonksen PH;
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):315-22. PubMed ID: 15730413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction.
    Tivesten A; Caidahl K; Kujacic V; Sun XY; Hedner T; Bengtsson BA; Isgaard J
    Growth Horm IGF Res; 2001 Jun; 11(3):187-95. PubMed ID: 11735233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early effects of streptozotocin-induced diabetes on insulin-like growth factor-I in the kidneys of growth hormone-transgenic and growth hormone-deficient dwarf mice.
    Jacobs ML; Chandrashekar V; Bartke A; Weber RF
    Exp Nephrol; 1997; 5(4):337-44. PubMed ID: 9259189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-I treatment increases motility and improves morphology of immature spermatozoa in the GH-deficient dwarf (dw/dw) rat.
    Vickers MH; Casey PJ; Champion ZJ; Gravance CG; Breier BH
    Growth Horm IGF Res; 1999 Aug; 9(4):236-40. PubMed ID: 10512689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiographic assessment of cardiac morphology and function in mutant dwarf rats.
    Longobardi S; Cittadini A; Strömer H; Katz SE; Grossman JD; Clark RG; Morgan JP; Douglas PS
    Growth Horm IGF Res; 2000 Oct; 10(5):242-7. PubMed ID: 11042020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum growth hormone binding protein and hepatic GH binding sites in the Lewis dwarf rat: effects of IGF-I and GH.
    Barnard R; Mulcahy J; García-Aragón J; Wyse B; Owens PC; Rowlinson SW; Talamantes F; Baumbach WR; Waters MJ
    Growth Regul; 1994 Dec; 4(4):147-54. PubMed ID: 7756972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies of the possible mechanisms for protective effects of recombinant human growth hormone on intestinal mucosa barrier in rat sepsis].
    Huang Y; Yi C; Long Y; Zhao QL; Jiang CX; Cui YX; He RH; Wang SR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):10-3. PubMed ID: 16468631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of resistance exercise and growth hormone administration at low doses on lipid metabolism in middle-aged female rats.
    Yang JY; Nam JH; Park H; Cha YS
    Eur J Pharmacol; 2006 Jun; 539(1-2):99-107. PubMed ID: 16687135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 axis in rats with liver cirrhosis].
    Liang LJ; Luo SM; Hu WJ
    Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(11):697-701. PubMed ID: 16008955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental diabetic renal growth: role of growth hormone and insulin-like growth factor-I.
    Muchaneta-Kubara EC; Sayed-Ahmed N; Besbas N; Zhang G; Cope GH; el Nahas AM
    Nephrol Dial Transplant; 1994; 9(10):1395-401. PubMed ID: 7816251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of tamoxifen effects on the actions of triiodothyronine or growth hormone in the ovariectomized-hypothyroid rat.
    Fitts JM; Klein RM; Powers CA
    J Pharmacol Exp Ther; 1998 Jul; 286(1):392-402. PubMed ID: 9655884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I.
    Clark RG; Mortensen DL; Carlsson LM; Carlsson B; Carmignac D; Robinson IC
    Endocrinology; 1996 May; 137(5):1904-12. PubMed ID: 8612530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor necrosis factor agent PEG-sTNFRI improves the growth hormone/insulin-like growth factor-I system in adjuvant-induced arthritic rats.
    Granado M; Priego T; Martín AI; Vara E; López-Calderón A; Angeles Villanúa M
    Eur J Pharmacol; 2006 Apr; 536(1-2):204-10. PubMed ID: 16545800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH) regulation of gastric structure and function in the GH-deficient rat: up-regulation of intrinsic factor.
    Lobie PE; García-Aragón J; Waters MJ
    Endocrinology; 1992 May; 130(5):3015-24. PubMed ID: 1374019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
    Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.